Tercica, Genentech File Motion To Block Insmed Growth Therapy

Law360, New York (May 31, 2005, 12:00 AM EDT) -- Drug makers Tercica Inc. and Genentech Inc. have have filed a motion for a preliminary injunction to block Insmed Inc. from bringing its SomatoKine growth therapy to market ahead of a pending patent infringement lawsuit.

The motion, filed in the U.S.District Court for the Northern District of California, seeks to bar Insmed from making SomatoKine and to force Insmed to grant Tercica joint exclusivity in any “orphan drug” marketing right that Insmed might receive if its application for its drug is approved before Tercica’s rival drug....
To view the full article, register now.